Latest Biotechnology, Pharmaceutical and Healthcare News from PharmaBiz

10:14 EDT 16th October 2018 | BioPortfolio

Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.

More Information about PharmaBiz on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.

Showing News Articles 1–25 of 816 from PharmaBiz

Tuesday 16th October 2018

Targovax announces encouraging disease─free survival data from Tg01 clinical trial in resected pancreatic cancer

Targovax ASA, a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announced the full data set from the 32─patient phase I/II clinical trial evaluating TG01 in resected pancreatic

EMA's COMP issues positive opinion on orphan drug status for Santhera's POL6014 to treat cystic fibrosis

Santhera Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on orphan drug designation for POL6014

IPA AC 2018 to discuss ways to bring back pharmaceutical sector in Odisha. Dr. Sruti Renjan Mishra

Odisha Pharmacy Intellectual Forum (OPIF) in association with IPA Jeypore local branch is gearing up to host the 12th Annual Convention of the Indian Pharmaceutical Association (IPA AC) on November 3 & 4 in Bhubaneswar.

Monday 15th October 2018

Bristol─Myers Squibb's phase 3 CheckMate─331 study does not meet primary endpont

Bristol─Myers Squibb Company announced topline results from the phase 3 CheckMate ─331 study evaluating Opdivo (nivolumab) versus the current standard of care, topotecan or amrubicin (where approved), in patients

Tab. Paracetamol 500mg In Strip Packing

Tab. Paracetamol 500mg In Strip Packing

Lupin gets US FDA tentative approval for generic lurasidone hydrochloride tablets

Lupin has received tentative approval for its lurasidone hydrochloride tablets, 20 mg, 40 mg, 60 mg, 80,mg and 120 mg from US FDA to market a generic version of Sunovion Pharmaceuticals Inc's Latuda tablets.

IICT signs MoU with US based NDT for developing side effect free cancer drug in 5 years

Hyderabad based Indian Institute of Chemical Technology (IICT) has recently signed a Memorandum of Understanding (MoU) with US based Nano Dev Therapeutics (NDT) to conduct clinical trials for developing a

US FDA approves Progenika Biopharma's ID CORE XT, a new DNA─based test to determine blood compatibility

The US Food and Drug Administration approved ID CORE XT, a molecular─based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood

Researchers develop new vaccine for Lassa fever & rabies

A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.

IICT sings MoU with US based NDT for developing side effect free cancer drug in 5 years

Hyderabad based Indian Institute of Chemical Technology (IICT) has recently signed a Memorandum of Understanding (MoU) with US based Nano Dev Therapeutics (NDT) to conduct clinical trials for developing a

Saturday 13th October 2018

Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting

Theravance Biopharma, Inc and Mylan NV announced that positive new data from multiple studies of Yupelri (revefenacin) inhalation solution were presented at the 2018 CHEST annual meeting, which was held in

Pylote, Amcor join hand to provide innovative packaging solutions for liquid pharmaceuticals

Pylote, a new player in the clean tech industrial mineral and ceramic chemistry, and Amcor, a global leader in responsible packaging solutions, announced at CPhI Worldwide in Madrid, Spain (9─11 October 2018), a

SpineEX receives US FDA approval for Sagittae lateral lumbar interbody fusion device

SpineEX, Inc, a medical device company that aims to provide innovative and minimally invasive implants, high─value disposables and instrumentation for spinal fusion surgeries, has received 510(k) clearance

Chinese drug authority accepts Eisai's NDA for Perampanel to treat partial onset seizures

Eisai Co, Ltd has announced that the National Medical Products Administration of China has accepted for review a New Drug Application for Eisai's antiepileptic drug (AED) perampanel (generic name, product

Indian, UK authorities clamp down on international medicines crime

In an effort to prevent unlicensed medicines entering into the UK market, the Medicines and Healthcare products Regulatory Agency (MHRA) of UK is working closely with law enforcement agencies in India.

Friday 12th October 2018

MEI Pharma, BeiGene ink clinical collaboration to evaluate ME─401 in combo with zanubrutinib to treat B─cell malignancies

MEI Pharma, Inc., a late─stage pharmaceutical company focused on advancing new therapies for cancer, and BeiGene, Ltd., a commercial─stage biopharmaceutical company, announced a clinical collaboration to

Medanta─AyurVAID launched to integrate modern medicine and Ayurveda

Medanta The Medicity in collaboration with AyurVAID Hospitals, launched Medanta─AyurVAID. Developed on a unique approach which optimises a fusion of modern medicine and ancient disciplines of therapy,

Carrick Therapeutics in─licenses exclusive worldwide rights to develop and commercialise ovarian cancer drug from BTG

Carrick Therapeutics, a biopharmaceutical company focusing on the innovative research and development of transformative oncology medicines, has licensed exclusive worldwide rights to develop and

Experts express concern about lack of awareness leading to rise in swine flu cases in Telangana

With the state health department of Telangana taking less initiatives to create awareness about seasonal diseases, the rise in cases of swine flu has become a major cause of concerns among the health experts in the state.

Thursday 11th October 2018

Rising burden of NCDs impacts Indian healthcare scene

Gagan Singh Bedi, managing director, AstraZeneca Pharma India

Quest launches GDN to improve healthcare by increasing access to diagnostic insights around the world

Quest Diagnostics, the world's leading provider of diagnostic information services, announced jointly with other leading diagnostic services providers the formation and launch of the Global Diagnostics Network

Teewinot launches new subsidiary, Canalis Pharmaceuticals

Teewinot Life Sciences Corporation, a global leader in the production of cannabinoid molecules, announces the launch of a new subsidiary, Canalis Pharmaceuticals, which will be led by Dr Steve Orndorff as CEO.

RaySearch, Canon Medical ink collaboration pact to advance software products & imaging systems

RaySearch Laboratories AB (publ), medical technology company, and Canon Medical Systems Corporation (Canon Medical) have entered into a collaboration agreement to facilitate a close integration between

Gujarat FDCA identifies 27,982 TB patients in its drive to serve them with effective treatments

The Gujarat Food and Drug Control Administration (FDCA) has identified 5,674 patients in 373 retail drug stores in the month of September 2018 as part of regulator's massive drive to serve the

Wednesday 10th October 2018

Cactus' Korea head appointed as chair of Council of Asian Science Editors

Basil D'Souza, head of Korea Operations, Cactus Communications, was recently appointed as the Chair of External Affairs for the Council of Asian Science Editors (CASE) in South Korea.

Quick Search


News Quicklinks